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Background: This study investigated to detect the content of remodeling markers of the respiratory tract in the exhaled breath 
condensate (EBC) of children with bronchial asthma (BA). Materials and Methods: The study was in clinical groups of 
children with BA were formed on the indices in sputum supernatant: the Group I ‑ “a high risk group” of bronchial remodeling 
(37 patients with vascular endothelial growth factor (VEGF) more than 80 ng/ml, and matrix metalloproteinase‑9 (MMP‑9) 
more than 5.2 ng/ml), the Group ІІ ‑ “a moderate risk” of bronchial remodeling (41 patients with VEGF more than 80 ng/ml, 
and MMP‑9 <5.2 ng/ml, or VEGF <80 ng/ml, and MMP‑9 more than 5.2 ng/ml), the Group ІІІ ‑ “a low risk” of bronchial 
remodeling (38 patients with VEGF did not achieve 80 ng/ml, and ММР‑9 <5.2 ng/ml). Results: The results obtained enable 
to believe that in EBC of children with a high risk of bronchial remodeling was higher azoalbumin olysis (1.8 ml/h comparison 
of Group II ‑ 1.5 ml/h, P = 0.038, and Group III ‑ 1.4 ml/h, P = 0.007), high catalase activity (81.26 comparison of other 
group ‑ 50.7, P = 0.06, and 47.07, P = 0.052  μmol/min/mg of protein). Furthermore, in the clinical Group I, the content of 
nitrogen monoxide metabolites (53.5 mcmol/L) comparison of Group II of children (48.7 mcmol/L, P = 0.28) and the Group III 
(41.7 mcmol/L, P = 0.085). Conclusions: In children with a “high risk” of respiratory tract remodeling more significant 
inflammatory process in the bronchi is found than in children with a “low risk.”
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stagnation phenomena, and increased general volume of 
the vascular bed are accompanied by bronchial obstruction, 
persisting inflammation, increased the temperature on the 
mucous surface with increased concentration of nitrogen 
monoxide in the exhaled breath. All these factors promote 
hyperactivity of the bronchi, their reduced function, 
intensified course of the disease, and in some extent, it 
influences upon the efficacy of treatment.3‑5 Thus, the aim 
of the research was to detect the content of remodeling 
markers of the respiratory tract in the exhaled breath 
condensate (EBC) of children suffering from bronchial 
asthma (BA).
InTRoduCTIon
The term “remodeling” usually means changes in the 
structure of the tissue content occurring as a result of 
disorders of natural reparation mechanisms in case of 
their damage. As a rule, remodeling occurs in individuals 
susceptible to this process in case of chronic inflammation, 
tissue damage, or combination of these factors. The signs of 
stable vascular alteration of the respiratory tract in case of 
bronchial remodeling are determined by their hypertrophy 
and angiogenesis manifested by 2–3 times increased 
number of vessels in the area of small and middle‑size 
bronchi.1,2 Increased permeability of the vascular wall, 
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MATERIAlS And METhodS
To achieve the purpose, 116 children suffering from 
persisting BA were examined at the Allergological Department 
of the Municipal Clinical Hospital “Regional Children Clinical 
Hospital” in Chernivtsi (Ukraine) in parallel groups applying 
the method of simple random sampling. Three clinical 
groups were formed on the basis of detected concentrations 
of vascular endothelial growth factor (VEGF) and matrix 
metalloproteinase‑9 (MMP‑9) in sputum supernatant of the 
patients examined. The first (І) clinical group further marked 
as “a high risk group” concerning formation of bronchial 
remodeling included 37 patients with the content of VEGF 
in sputum supernatant more than 80 ng/ml, and MMP‑9 
more than 5.2 ng/ml (67.6% of boys with an average age 
12.0 ± 0.46). The second (ІІ) group marked as “a moderate 
risk group” of bronchial remodeling included 41 patients with 
VEGF level in sputum supernatant fluid more than 80 ng/ml, 
and MMP‑9 <5.2 ng/ml, or VEGF content <80 ng/ml, and 
MMP‑9 more than 5.2 ng/ml (61.0% of boys with an average 
age 11.5 ± 0.54). The third (ІІІ) clinical group included 
38 patients with BA further marked as “a low risk group” of 
bronchial remodeling. The concentration of VEGF in sputum 
supernatant of this group did not achieve 80 ng/ml, and ММР‑9 
did not exceed 5.2 ng/ml (67.8% of boys with an average age 
of 11.2 ± 0.52). The duration of BA in the Group I of children 
was 5.8 ± 0.68 years, in Group II 4.4 ± 0.68 years, and in the 
low‑risk group of bronchial remodeling – 4.4 ± 0.63 years 
(in all the cases Р > 0.05). Therefore, the groups of comparison 
were compared by the main clinical characteristics.
To obtain sputum, the procedure of induction was carried 
out by means of inhalation of sodium chloride serial hypertonic 
solutions by Pavord et al.6 Biomarkers of bronchial remodeling 
in sputum supernatant were detected in the following way: 
VEGF – by means of three‑stage “sandwich”‑variant of the 
solid‑phase immune‑enzyme analysis using monoclonal 
and polyclonal antibodies (reagents «VEGF‑Vector‑Best» 
А‑8784, RF), MMP‑9 – by means of “sandwich”‑ELISA 
method (reagents “Affymetrix eBioscience” BMS 
2016/2/BMS2016/2TEN (Bender MedSystems, GmbH, 
Austria).
EBC was collected by means of our designed and patented 
device in terms of recommendations.7 During 10–15 min of 
free respiration, usually, 1.5–2.0 ml of EBC was obtained 
in which the following indices were detected: Total protein 
content (g/L) by Lowry’s method, EBC proteolytic activity 
by the lysis of albumin, azocasein, and azocollagen by 
Veremeyenko’s method, the content of aldehyde and ketone 
derivatives of 2,4‑dinitrophenylhydrazone (AKDNPH) of the 
main and neutral character by Dubinina’s method, the content 
of  nitrogen monoxide metabolites (NMON) by Yemchenko’s 
method (1994) in Gozhenko’s modification (2002), total, 
enzymatic, and non‑enzymatic fibrinolytic activity by 
Kukharchuk’s method.
The results obtained were analyzed by means of the 
computer packages Statistica 6.0 and Excel XP for Windows 
using parametric and non‑parametric calculation methods. 
Diagnostic value of the test was estimated considering 
sensitivity (Se), specificity (Sp), prognostic value of positive 
and negative results (PVPR and PVNR), likelihood ratio of 
the positive (LR+), and negative (LR−) results. In all cases, 
confidence 95% interval was detected (95% confidence 
interval [CІ]). Risk assessment evaluation was carried out 
considering the values of relative, attributive risk, chance ratio 
with detection of their 95% CI.
RESulTS
According to the degree of severity BA in the clinical 
Group I of patients was distributed in the following way: 
severe form – in 13.5% of patients, moderate – in 62.2% of 
children and mild persisting – in 24.3% of patients. In the 
clinical Group II, severe variant of the disease constituted 
19.5%, moderate – 41.5%, and mild – 39.0% (in all the cases 
Р > 0.05). In the group of children with a low risk of bronchial 
remodeling, the patients with a severe persisting course of 
BA constituted 23.7%, moderate – 34.3%, and mild –42.0% 
(in all the cases Р > 0.05). According to the form, BA was 
distributed in the following way: atopic form was found in 
67.6% of patients in Group I, in 56.1% of children from the 
moderate risk group and in 63.2% of representatives of the 
Group III of comparison (in all the cases Р > 0.05), a mixed 
form of the disease was found in the rest of children.
Table 1 presents the values of total protein content and 
products of its oxidative modification in EBC.
Therefore, an inconsiderable increase of the total protein 
concentration in EBC was found in the part of children that in 
Table 1: The values of protein oxidative modification and 
the content of total protein in exhaled breath condensate of 
children
Clinical groups Total 
protein (g/L)
AKDNPH of the 
main character 
(Е370 mmol/g of 
protein)
AKDNPH of the 
neutral character 
(Е370 mmol/g of 
protein)
Group І (n=37) 3.3±0.23 52.4±12.67 7.0±2.70
Group II (n=41) 3.8±0.29 65.7±9.66 6.3±0.71
Group III (n=38) 3.7±0.60 59.3±17.84 6.4±1.67
P >0.05 >0.05 >0.05
AKDNPH=Aldehyde and ketone derivatives of 2,4‑dinitrophenylhydrazone
Olena Kostiuntynivna Koloskova, et al.
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general did not differ reliably from the value of the regional 
norm (3.3 ± 0.2 g/L). It can be explained by lower activity of 
an inflammatory process in the bronchi in children from the 
Groups I and II associated with reduced transudation of protein 
through the vascular wall. At the same time, an increased 
content of aldehyde and ketodinitrophenylhydrazones of a 
neutral character proves a higher activity of an inflammatory 
process in children from the Group I of comparison.
Table 2 presents proteolytic (ml/h) and fibrinolytic (μg 
azofibrin/ml per 1 h) EBC activity in children from the groups 
of observation.
The results obtained enable to believe that higher 
proteolytic and enzymatic EBC activity is found in children 
with a high risk of bronchial remodeling. EBC proteolytic 
activity according to azoalbumin olysis more than 1.8 ml/h 
possessed the following indices of diagnostic value 
concerning detection of a high risk of structural changes in 
the bronchi: Test sensitivity (TS) – 11.1% (95% CІ 5.7–19.0), 
TS – 91.9% (95% CІ 84.7–96.4) with predicted value of 
positive and negative results 57.2% (95% CІ 33.0–79.3) 
and 51.3% (95% CІ 43.8–58.8). Posttesting probability of 
a positive result became 7.7% increased, and in case of a 
negative result, it became 0.8% decreased. Therefore, in spite 
of high TS its diagnostic value, in general, was insignificant 
that was evidenced by probability indices of the positive (1.4) 
and negative (1.0) results.
At the same time, it should be noted that catalase activity 
performing the role of an extracellular “scavenger” achieved 
in an average 81.26 mcmol/min in the clinical Group I, in 
the children from the Group II 50.7, and in the Group ІІІ 
47.07 mcmol/min/mg of protein (P < 0.05), which is indicative 
of less inflammation activity in patients from the clinical 
Groups II and III. Table 3 presents the diagnostic value of 
exhaled air condensate indices in BA patients with a high risk 
of bronchial remodeling.
Application of these tests to detect children with a high risk 
of bronchial remodeling increased LR in case of a positive 
result: For the content of total protein more than 4.0 g/L – on 
5.8%, for the markers of protein peroxide oxidation of the 
main character of the above‑mentioned value – on 3.9%, 
and for catalase activity indicated above – on 68.3%. In case 
of a negative result of the test probability of a high risk of 
bronchial remodeling development became 5.2%, 1.6%, and 
4.8% decreased, respectively. Table 4 presents the indices of 
high‑risk probability of bronchial remodeling in children.
The data presented are indicative of the fact that only 
catalase activity in EBC higher than the point of distribution is 
indicative of a probable risk of high likelihood concerning the 
development of structural changes in the bronchi.
Considering the fact that the content of nitrogen monoxide 
metabolites (NMOM) in EBC reflects the activity of an 
inflammatory process, especially in patients with eosinophilic 
bronchitis, making an analysis of this index seemed to be 
reasonable. Thus, its content in the I clinical group was 
53.5 mcmol/L in an average, in the Group II of children – 48.7, 
and in the Group III – 41.7 mcmol/L (P > 0.05), which is 
indicative of a higher inflammation activity in patients from 
the clinical Groups 1 and II. It is an interesting fact that more 
Table 2: The values of fibrinolysis and proteolysis in exhaled breath condensate of children from the groups of observation
Clinical groups Values of EBC proteolytic activity Values of EBC fibrinolytic activity
By albuminolysis By azocasienolysis By azocololyis TFA NFА EFА
Group I (n=37) 1.8±0.02 1.4±0.03 0.3±0.01 0.93±0.02 0.49±0.01 0.53±0.01
Group II (n=41) 1.5±0.05 1.4±0.05 0.2±0.02 0.87±0.03 0.39±0.01 0.48±0.02
Group III (n=38) 1.4±0.04 1.4±0.06 0.2±0.02 0.91±0.05 0.43±0.02 0.48±0.02
P I:II, III <0.05 >0.05 I:II, III <0.05 >0.05 >0.05 I: II, III <0.05
TFA=Total fibrinolytic activity; NFA=Nonenzymatic fibrinolytic activity; EFA=Enzymatic fibrinolytic activity; EBC=Exhaled breath condensate
Table 3: Diagnostic value of exhaled breath condensate indices concerning detection of a high risk of bronchial 
remodeling
EBC indices Diagnostic value (95% CІ) LR
Test sensitivity Test specificity Prognostic value PR NR
PR NR
Total protein content >4.0 g/L 52.6 (42.3‑62.7) 58.3 (48.0‑68.1) 55.8 (45.2‑66.0) 55.2 (45.1‑64.0) 1.3 0.8
AKDNPH of the main character >60.0 mmol/g of protein 31.2 (22.3‑41.3) 73.3 (63.5‑81.7) 53.9 (40.2‑67.1) 51.6 (43.0‑60.6) 1.2 0.9
Catalase activity >80.0 mcmol/min/mg of protein 28.6 (20.0‑38.5) 86.7 (78.4‑92.7) 68.3 (52.0‑81.9) 54.8 (46.7‑62.8) 2.2 0.8
AKDNPH=Aldehyde and ketone derivatives of 2,4‑dinitrophenylhydrazone; CI=Confidence interval; LR=Likelihood ratio; PR=Positive result; 
NR=Negative result; EBC=Exhaled breath condensate
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frequent increased content of NMOM in EBC is found among 
the representatives of all the groups. Thus, the content of NO 
metabolites in EBC more than 40.0 mcmol/L in the Group I 
was found in 56.5% cases, in the Group II – in 58.8%, 
and in the group of patients with a low risk of bronchial 
remodeling – in 38.5% of observations (PI, II: III <0.05). It 
should be noted that diagnostic value as to the detection of 
patients with a high risk of bronchial remodeling according 
to the content of nitrogen monoxide metabolites in EBC more 
than 40.0 mcmol/L was insufficient: TS – 56.5% (95% CІ 
46.2–66.4), TS – 61.5% (95% CІ 51.2–71.1), PVPR – 59.5% 
(95% CІ 48.9–69.4), PVNR – 58.6% (95% CI 48.5–68.1); 
LR+ – 9.5%, LR (−) – 8.6%.
dISCuSSIon
Thus, in children with “high risk” of respiratory tract 
remodeling more pronounced inflammatory process in the 
bronchi is found than in children with “low risk” which is 
evidenced by certain literary data. For example, Holgate,8,9 who 
can be considered as one of the founder of inflammatory theory 
of disease, proved in the results of his experimental works 
that congenital or acquired inability of the epithelial barrier 
results in disorders of the epithelial‑mesenchymal interaction, 
chronic inflammation, pro‑inflammatory mediators secretion, 
increased sensitivity of the bronchial functional structures to 
them, and finally, to their remodeling. At the same time, in case 
of a repeated action of aggressive stimuli this inflammatory 
response acquires a chronic character. Herewith, disorders of a 
natural succession of the epithelial layer restoration processes 
occur, the processes of the epithelial cells migration are initiated 
under the influence of growth factors, secretion of extracellular 
matrix proteins and pro‑inflammatory mediators take place.10‑12 
It might be due to this fact that higher activity of proteolysis 
according to albuminolysis and azocololysis, higher indices of 
the condensate fibrinolytic activity, and more frequent detection 
of nitrogen monoxide metabolites content were found.
ConCluSIonS
The results of EBC examination obtained enable to 
believe that in children with a “high risk” of respiratory tract 
remodeling more significant inflammatory process in the 
bronchi is found, than in children with a “low risk” which is 
proved by higher fibrinolytic and proteolytic activity, higher 
level of nitrogen monoxide metabolites, and it requires more 
aggressive basic anti‑inflammatory therapy for these patients.
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